Boehringer Ingelheim Analysis

Treat chronic diseases in humans with innovative medications; Vaccinate livestock to prevent disease outbreaks; Develop biopharmaceuticals for complex medical conditions; Enhance animal welfare through advanced health solutions; Support veterinarians with effective treatment options

Operates in over 150 countries; Invested heavily in R&D, with 10,000+ employees in this area; Recognized for sustainability initiatives in healthcare

Main Information

• Information: Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health, focusing on innovative therapies in areas of high unmet medical need. The company has been independent since its foundation in 1885 and emphasizes sustainability throughout its value chain. It employs over 53,500 people and serves more than 130 markets.
• Interests: HEALTH/FITNESS/WELLBEING
• Location: Hall 8.0 – 4YFN & Partner Theatres Stand 8.0B11.1
• Whether tagged as startup: No

Contact & Links

• LinkedIn: Connect on LinkedIn
• Twitter: Follow on X (formerly Twitter)
• Phone Number: Not available
• Email: Email

Key Information

• Growth Stage: Not available
• Country: Not available
• Founding Year: 1885

Company Context

Company Name: Boehringer Ingelheim; Company Website: https://www.boehringer-ingelheim.com